Related references
Note: Only part of the references are listed.The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress
Afsane Bahrami et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Ricardo L. B. Costa et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells
Nazlihan Aztopal et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Barbara Pasculli et al.
SEMINARS IN CANCER BIOLOGY (2018)
Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas
Lili Li et al.
THERANOSTICS (2018)
ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
Sophia Mastoraki et al.
CLINICAL CANCER RESEARCH (2018)
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2017)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Chemical Analysis of Morphological Changes in Lysophosphatidic Acid-Treated Ovarian Cancer Cells
Karen A. Bailey et al.
SCIENTIFIC REPORTS (2017)
MYC-Driven Pathways in Breast Cancer Subtypes
Yassi Fallah et al.
BIOMOLECULES (2017)
ChAMP: updated methylation analysis pipeline for Illumina BeadChips
Yuan Tian et al.
BIOINFORMATICS (2017)
Implications of the lysophosphatidic acid signaling axis in liver cancer
Chiara Lopane et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
Nikolaos Garmpis et al.
CANCER GENOMICS & PROTEOMICS (2017)
Lysophosphatidic acid (LPA) signaling via LPA4 and LPA6 negatively regulates cell motile activities of colon cancer cells
Kaede Takahashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
The PI3K/AKT Pathway as a Target for Cancer Treatment
Ingrid A. Mayer et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells
Sarandeep S. S. Boyanapalli et al.
PHARMACOLOGICAL RESEARCH (2016)
Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells
Shuhei Ishii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
Smita Matkar et al.
CANCER CELL (2015)
Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
Elias E. Stratikopoulos et al.
CANCER CELL (2015)
Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
Antonio Mazzocca et al.
CANCER RESEARCH (2015)
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer
Anand Kamal Singh et al.
CLINICAL CANCER RESEARCH (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
ChAMP: 450k Chip Analysis Methylation Pipeline
Tiffany J. Morris et al.
BIOINFORMATICS (2014)
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
Zsofia Penzvalto et al.
BMC CANCER (2014)
IncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals
Zhen Xing et al.
CELL (2014)
The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
J. Zhu et al.
ONCOGENE (2014)
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
A. Ketscher et al.
ONCOGENESIS (2014)
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma
Eugene Sokolov et al.
JOURNAL OF SURGICAL RESEARCH (2013)
MYC, Metabolism, Cell Growth, and Tumorigenesis
Chi V. Dang
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Visualizing multidimensional cancer genomics data
Michael P. Schroeder et al.
GENOME MEDICINE (2013)
Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas
Venkat R. Katkoori et al.
PLOS ONE (2012)
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
M. P. Roberti et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Identification of early molecular markers for breast cancer
Celine Kretschmer et al.
MOLECULAR CANCER (2011)
NCBI GEO: archive for functional genomics data sets-10 years on
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2011)
Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells
Sanaa Al Saleh et al.
PLOS ONE (2011)
Evaluation of the Infinium Methylation 450K technology
Sarah Dedeurwaerder et al.
EPIGENOMICS (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Timing is everything: Order of administration of 5-aza 2′ deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity
Christine L. Hostetter et al.
CANCER LETTERS (2009)
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Jessica Marlind et al.
CLINICAL CANCER RESEARCH (2008)
Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair
Yutaka Shimomura et al.
NATURE GENETICS (2008)
Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers
Hongchuan Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bioinformatics approaches in the study of cancer
David A. Hanauer et al.
CURRENT MOLECULAR MEDICINE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Share Paper
